Are Phe-Free Protein Substitutes Available in Italy for Infants with PKU All the Same?
Nutrients · 2023
DOI: 10.3390/nu16010030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Elvira Verduci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Diseases Unit, Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, 20154 Milan, Italy. Hauptthemen laut MEDLINE: Phenylalanine, Nutrients. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Sciences of the University of Milan, Milan, Italy.
Abstract (Originalsprache)
Breastfeeding or standard infant formulas, alongside phenylalanine (Phe)-free protein substitutes, constitute the dietary management for infants with PKU to guarantee protein requirements are met in compliance with metabolic tolerance. This work aims to analyse the nutritional composition of Phe-free infant protein substitutes, in terms of macronutrients, micronutrients and functional components, available for PKU dietary management in Italy. A total of seven infant Phe-free protein substitutes were included in this review, six powder and one liquid. A second analysis was conducted to compare them to the composition of formulas intended for healthy infants, taking into consideration the Commission Delegated Regulation (EU) 2016/127 and Commission Delegated Regulation (EU) 2016/128 for micronutrients. The analysis revealed heterogeneity among protein substitutes suitable for infants with PKU. The energy and protein equivalents (P.Eq.) content are different; all of the substitutes contain docosahexaenoic acid (DHA) and arachidonic acid (ARA), while eicosapentaenoic acid (EPA), fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), human milk oligosaccharides (HMOs) and nucleotides are not present in all the substitutes. More attention should be paid to these infant products to ensure metabolic control of PKU, and also promote proper growth, cognitive neurodevelopment, favourable gut microbiota composition, and immune system health, while reducing the risk for non-communicable diseases (NCDs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Diseases Unit, Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, 20154 Milan, Italy.
- Department of Health Sciences, University of Milan, 20146 Milan, Italy.
- Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, 20154 Milan, Italy.
- Department of Biomedical and Clinical Science, University of Milan, 20157 Milan, Italy.
- U.O.C. Pediatrics and Neonatology, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
- Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
ORCID-Profile: Elvira Verduci, Martina Tosi, Chiara Montanari, Margherita Di Costanzo, Giacomo Biasucci, Laura Fiori, Gianvincenzo Zuccotti
Förderung
- Department of Health Sciences of the University of Milan, Milan, Italy
Zitieren
APA
Verduci, E., Tosi, M., Montanari, C., Gambino, M., Eletti, F., Bosetti, A., Di Costanzo, M., Carbone, M. T., Biasucci, G., Fiori, L., & Zuccotti, G. (2023). Are Phe-Free Protein Substitutes Available in Italy for Infants with PKU All the Same?. Nutrients. https://doi.org/10.3390/nu16010030
Vancouver
Verduci E, Tosi M, Montanari C, Gambino M, Eletti F, Bosetti A, et al. Are Phe-Free Protein Substitutes Available in Italy for Infants with PKU All the Same?. Nutrients. 2023. doi:10.3390/nu16010030
BibTeX
@article{Verduci2023,
author = {Verduci, Elvira and Tosi, Martina and Montanari, Chiara and Gambino, Mirko and Eletti, Francesca and Bosetti, Alessandra and Di Costanzo, Margherita and Carbone, Maria Teresa and Biasucci, Giacomo and Fiori, Laura and Zuccotti, Gianvincenzo},
title = {Are Phe-Free Protein Substitutes Available in Italy for Infants with PKU All the Same?},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu16010030}
}
EUVIMED